Minerva Neurosciences Statistics
Total Valuation
NERV has a market cap or net worth of $11.33 million. The enterprise value is $50.39 million.
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025, before market open.
Earnings Date | Apr 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NERV has 6.99 million shares outstanding. The number of shares has increased by 16.41% in one year.
Current Share Class | 6.99M |
Shares Outstanding | 6.99M |
Shares Change (YoY) | +16.41% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 4.02% |
Owned by Institutions (%) | 30.12% |
Float | 5.44M |
Valuation Ratios
The trailing PE ratio is 8.84.
PE Ratio | 8.84 |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | -0.46 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 35.02 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.85
Current Ratio | 7.85 |
Quick Ratio | 7.53 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.79 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -29.04% |
Return on Invested Capital (ROIC) | -31.08% |
Return on Capital Employed (ROCE) | -63.69% |
Revenue Per Employee | n/a |
Profits Per Employee | $179,858 |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.43% in the last 52 weeks. The beta is 0.09, so NERV's price volatility has been lower than the market average.
Beta (5Y) | 0.09 |
52-Week Price Change | -40.43% |
50-Day Moving Average | 2.04 |
200-Day Moving Average | 2.54 |
Relative Strength Index (RSI) | 39.54 |
Average Volume (20 Days) | 31,312 |
Short Selling Information
The latest short interest is 42,036, so 0.60% of the outstanding shares have been sold short.
Short Interest | 42,036 |
Short Previous Month | 20,897 |
Short % of Shares Out | 0.60% |
Short % of Float | 0.77% |
Short Ratio (days to cover) | 1.16 |
Income Statement
Revenue | n/a |
Gross Profit | -11.90M |
Operating Income | -21.85M |
Pretax Income | -33.65M |
Net Income | 1.44M |
EBITDA | -21.84M |
EBIT | -21.85M |
Earnings Per Share (EPS) | $0.19 |
Full Income Statement Balance Sheet
The company has $21.36 million in cash and $60.00 million in debt, giving a net cash position of -$38.64 million or -$5.52 per share.
Cash & Cash Equivalents | 21.36M |
Total Debt | 60.00M |
Net Cash | -38.64M |
Net Cash Per Share | -$5.52 |
Equity (Book Value) | -25.69M |
Book Value Per Share | -3.67 |
Working Capital | 19.43M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -19.55M |
Capital Expenditures | n/a |
Free Cash Flow | -19.55M |
FCF Per Share | -$2.80 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NERV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.41% |
Shareholder Yield | n/a |
Earnings Yield | 12.25% |
FCF Yield | -166.40% |
Analyst Forecast
The average price target for NERV is $5.00, which is 208.64% higher than the current price. The consensus rating is "Hold".
Price Target | $5.00 |
Price Target Difference | 208.64% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | 87.53% |
Stock Forecasts Stock Splits
The last stock split was on June 21, 2022. It was a reverse split with a ratio of 0.125:1.
Last Split Date | Jun 21, 2022 |
Split Type | Reverse |
Split Ratio | 0.125:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |